Notes to Accounts of Ajooni Biotech Ltd.

Mar 31, 2025

B. NOTES ON ACCOUNTS

''1. Previous year figure have been re-grouped / re¬
arranged / re-caste wherever considered necessary,
to suit the current year''s layout as per the Performa
of Revised Schedule III of IND AS.

''2. In the opinion of the Board, the current assets,
loans & advances have a value on realization in the
ordinary course of business at least equal to the
amount at which they are stated in the balance sheet
and that the provision for known liabilities are
adequate and not in excess of amount reasonably
necessary.

1. EPS CALCULATION
Basic earnings per share

Basic earnings per share is calculated by dividing

A) the profit/(loss) attributable to owners of
the company

B) by the weighted average number of equity
shares outstanding during the financial
year, adjusted for bonus elements in
equity shares issued during the year

Diluted earnings per share adjusts the figures used
in the determination of basic earnings per share to
take into account:

A) the after income tax effect of interest and
other financing costs associated with
dilutive potential equity shares'' and

B) the weighted average number of
additional equity shares that would have
been outstanding assuming the conversion
of all dilutive potential equity years.

2. With reference to Employee Benefits, provision has been made regarding Gratuity, on basis of actuarial
valuation and their impact on financial statements is ascertained in FY 2024-25, However impact in
previous year remains unascertained.

a) Related Party disclosures are required under the Accounting standard (IAS-24) on "Related Party
Disclosures" issued are given below:-

b) Relationship-

(i) Holding Company - None

(ii) Key Management Personnel (Managing / Whole Time Director) -

i) Jasjot Singh - MD/CFO

ii) Gursimran Singh - Whole Time Director

iii) Swati Vijan - Company Secretary

iv) Partek Singh - Executive Director

v) Simmi Chhabra - Independent Woman Director

vi) Ramandeep Singh - Independent Director

vii) Imteshwar Singh Bhatia - Independent Director

viii) Ishtneet Bhatia - Independent Director (w.e.f. 03.01.2025)

(iii) Entities over which key management personnel / their Relatives are able to exercise significant

influence

a) Punjab Biotechnology Park Limited
Mr. Jasjot Singh- Common Director
c) M/s. Khanna Solvex

Mr. Jasjot Singh- Partner in the partnership Firm

17) Details of Shareholders

Details of Shareholders have been attached as per Annexure "B".

18) Others

''1) The company is engaged in business of selling Nil rated product i.e cattle feed, whose sales is
done on FOR basis according to which the rate charged included the transportation cost per unit
ascertained by company. The GST on such cost has not been ascertained by management due to
nature of product being sold.

19) Rounding of has been done to Lacs as per requirement of Schedule III.

20) Disclosure of Transactions with Struck off Company

''The company did not have any material transaction with companies struck off under Section 248 of the
companies Act 2013 or section 560 of the companies act 1956 during the financial year.

21) Additional Regulatory Disclosures

''No transaction to report against the following disclosures as notified by MCA Pursuant to

amendment in Schedule III

''a) Crypto Currency or virtual Currency

''b) Benami Property held under Prohibition of Benami Transactions Act, 1988 and rules made there
under

c) Registration of charges or satisfaction with Registrar of Companies

d) Compliance with number of layers of companies
''e) Relating to Borrowed funds

i) Willful Defaulter

ii) Utilization of Borrowed funds and share premium

iii) Borrowings obtained on the basis of Security of Current Assets

iv) Discrepancy in Utilization of Borrowings

v) Current Maturity of long-term borrowings
f) Title deeds of immovable properties.

For and on behalf of the Board For Narinder Kumar and

Company

Chartered Accountants
FRN : 0030737N

CA Narinder Kumar Garg
M.No 080287

Jasjot Singh Gursimran Singh Swati Vijan

Managing Director/ CFO Whole Time Director CS

Date: 26/05/2025
Place: Mohali

UDIN: - 25080287BMLITD5360

---

Mar 31, 2024

2. With reference to Employee Benefits, provision has been made regarding Gratuity, on basis of actuarial valuation and their impact on financial statements is ascertained in FY 2023-24, However impact in previous year remains unascertained.

6) The Balance in the parties account whether debit or credit are subject to confirmation, reconciliation and adjustment.

7) Estimated amount of contracts remaining to be executed on capital account and not provided for (Net of Advances).

8) Contingent Liabilities not provided for :	31st March, 2024	31st March, 2023
a. Bank Guarantees	Nil	Nil
b. Contingent Liabilities in respect of Unascertained Unassessed cases of Income Tax and Sales Tax.		Unascertained

c. Uncalled Liabilities as Shares partly paid	Nil	Nil
d. Claims not acknowledged as debts	Nil	Nil
e. Letter of Credit(s)	Nil	Nil
9) CIF value of imports	Nil	Nil
10) Remittance in foreign Currency	Nil	Nil
11) Expenditure in Foreign Currency	Nil	Nil
12) Earning in Foreign Currency * Received on account of export sales	Rs. 14,69,325.00	Rs. 11,61,400.00

years, until such date when the interest dues as above are actually paid to the small enterprise, for the purpose of dis allowance as a deductible expenditure under section 23.